# Farmako Healthcare **Source:** https://geo.sig.ai/brands/farmako-healthcare **Vertical:** Healthcare **Subcategory:** General **Tier:** Emerging **Website:** farmako.in **Last Updated:** 2026-04-14 ## Summary Bengaluru 30-minute medicine delivery with digital health records and chronic care management; YC W20 $3.1M at ₹10.7Cr revenue with 36% CAGR competing with PharmEasy and 1mg for India pharmacy delivery. ## Company Overview Farmako Healthcare is a Bengaluru-based healthtech platform — backed by Y Combinator (W20) and HOF Capital with $3.1 million raised including a $1.6 million round in August 2024 and a pre-Series A in June 2025 — providing ultra-fast medicine delivery (30-minute delivery within service areas), digital health records management, and personalized health insights for patients managing chronic conditions and routine pharmacy needs in Indian metros. Founded in 2019 and generating ₹10.7 crore (approximately $1.3 million USD) in annual revenue as of March 2024 with 36% revenue CAGR and a 63-person team, Farmako serves the medication adherence and pharmacy access market in India's urban health ecosystem. Farmako's speed-and-convenience model addresses the fundamental problem with Indian pharmacy access: traditional pharmacies cluster in commercial areas, operate 12-hour days, and require patients to carry prescriptions physically — a friction that leads to medication non-adherence among chronic disease patients (diabetes, hypertension) who may skip refills when inconvenient. Farmako's pharmacy network integrates with neighborhood pharmacies and distribution centers to enable 30-minute delivery, with the digital prescription management layer storing prescriptions in the app so patients never need physical copies for refills. The health insights module aggregates medication history, lab results, and health vitals to provide patients with health trend visibility. In 2025, Farmako competes in the Indian online pharmacy and health delivery market with PharmEasy (India's largest online pharmacy, $4.4B valuation, facing financial challenges), 1mg (Tata-owned online pharmacy and lab testing), and Apollo Pharmacy (Apollo Hospitals chain-owned, 5,000+ stores) for India's $20 billion+ pharmaceutical retail market. The Indian online pharmacy market has undergone consolidation and funding pressure after the 2022-2023 funding winter, with PharmEasy's valuation writedown highlighting the profitability challenges of quick-commerce pharmacy models. Farmako's focus on the chronic medication adherence use case and health records differentiation positions it above pure price-competition pharmacy delivery. The 2025 strategy focuses on growing the chronic disease management program (structured diabetes and hypertension care programs), expanding the insurance-linked pharmacy benefit channel, and building the diagnostic test booking integration. ## Frequently Asked Questions ### What is Farmako Healthcare? Farmako Healthcare is an India-based healthtech platform founded in 2019 that provides ultra-fast medicine delivery, health insights, and personal health record management. The company is backed by Y Combinator (W20 batch), HOF Capital, and 6 other investors. ### What products and services does Farmako Healthcare offer? Farmako Healthcare offers ultra-fast medicine delivery, online pharmacy services, health report insights, personal health records management, and prescription management. These services are designed to streamline healthcare access and health data management for users. ### Who is Farmako Healthcare designed for? Farmako Healthcare serves customers in India who need convenient access to medicines and want to manage their health records and prescriptions digitally. The platform is designed for anyone seeking fast medicine delivery and streamlined health information management. ### When was Farmako Healthcare founded? Farmako Healthcare was founded in 2019. The company was part of Y Combinator's Winter 2020 (W20) batch. ### Where is Farmako Healthcare based? Farmako Healthcare is based in India. The company operates as an India-based healthtech platform serving the Indian market. ### How much funding has Farmako Healthcare raised? Farmako Healthcare has raised $3.1M in total funding across 3 rounds. The company raised $1.6M on August 12, 2024, and completed a pre-Series A round in June 2025, with backing from Y Combinator, HOF Capital, and 6 other investors. ### What are Farmako Healthcare's key financial metrics and team size? As of March 31, 2024, Farmako Healthcare reported annual revenue of ₹10.7 Crore (approximately $1.3M USD) with a 36% revenue CAGR in the last year. The company has 63 employees as of April 30, 2025. ### What is Farmako Healthcare's approach to medicine delivery? Farmako Healthcare focuses on providing ultra-fast medicine delivery combined with digital health management tools. The platform integrates online pharmacy services with health record management and prescription tracking to create a comprehensive healthcare solution. ### How can I get started with Farmako Healthcare? Based on the provided information, specific contact details or onboarding instructions are not available. Farmako Healthcare operates as an online healthtech platform offering medicine delivery and health management services in India. ### What are the latest developments at Farmako Healthcare? Farmako Healthcare completed a pre-Series A funding round in June 2025, following a $1.6M funding round on August 12, 2024. The company achieved 36% revenue CAGR and reported ₹10.7 Crore in annual revenue as of March 31, 2024. ## Tags healthtech, saas, north-america, b2b --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*